1. Anti-herpetic activity of a combination of L'asparaginase and cytosine arabinoside used in vitro. Issue 572 (June 1973) Authors: Cappel, Roger; Klastersky, Jean; Thiry, Lise Journal: Postgraduate medical journal Issue: Volume 49:Issue 572(1973) Page Start: 428 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Biomarkers for adverse events associated with immune checkpoint inhibitors. (October 2016) Authors: Kourie, Hampig Raphael; Paesmans, Marianne; Klastersky, Jean Journal: Biomarkers in medicine Issue: Volume 10:Number 10(2016) Page Start: 1029 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Concurrent driver mutations/rearrangements in non-small-cell lung cancer. Issue 2 (March 2017) Authors: Tabchi, Samer; Kourie, Hampig R.; Klastersky, Jean Journal: Current opinion in oncology Issue: Volume 29:Issue 2(2017:Mar.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Development of the Multi-Dimensional Analysis of Patient Outcome Predictions (MD.POP) during medical encounters. Issue 1 (January 2018) Authors: Ménard, Catherine; Libert, Yves; Canivet, Delphine; Van Achte, Laetitia; Farvacques, Christine; Liénard, Aurore; Merckaert, Isabelle; Reynaert, Christine; Slachmuylder, Jean-Louis; Durieux, Jean-François; Klastersky, Jean; Razavi, Darius Journal: Patient education and counseling Issue: Volume 101:Issue 1(2018) Page Start: 52 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Editorial Introductions. Issue 1 (January 2023) Editors: Klastersky, Jean; Jungels, Christiane; Pirker, Robert; Zhou, Caicun Journal: Current opinion in oncology Issue: Volume 35:Issue 1(2023) Page Start: v Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Editorial introductions. Issue 2 (March 2022) Editors: Klastersky, Jean; Awada, Ahmad; Hainaut, Pierre Journal: Current opinion in oncology Issue: Volume 34:Issue 2(2022) Page Start: v Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Immune checkpoint inhibitors side effects and management. (June 2016) Authors: Kourie, Hampig Raphael; Klastersky, Jean Journal: Immunotherapy Issue: Volume 8:Number 7(2016:Jul.) Page Start: 799 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Impact of chemotherapy-induced neutropenia (CIN) and febrile neutropenia (FN) on cancer treatment outcomes: An overview about well-established and recently emerging clinical data. (December 2017) Authors: Lalami, Yassine; Klastersky, Jean Journal: Critical reviews in oncology/hematology Issue: Volume 120(2017) Page Start: 163 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Meta-analysis and indirect treatment comparison of lipegfilgrastim with pegfilgrastim and filgrastim for the reduction of chemotherapy-induced neutropenia-related events. (September 2018) Authors: Bond, T Christopher; Szabo, Erika; Gabriel, Susan; Klastersky, Jean; Tomey, Omar; Mueller, Udo; Schwartzberg, Lee; Tang, Boxiong Journal: Journal of oncology pharmacy practice Issue: Volume 24:Number 6(2018) Page Start: 412 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Old age: An extra risk for febrile neutropenia?. Issue 2 (March 2017) Authors: Klastersky, Jean; Lago, Lissandra Dal Journal: Journal of geriatric oncology Issue: Volume 8:Issue 2(2017) Page Start: 84 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗